Hudson Bay Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-329,400
Closed -$260K 250
2014
Q4
$260K Hold
329,400
0.01% 166
2014
Q3
$153K Buy
+329,400
New +$160K ﹤0.01% 200
2014
Q2
Sell
-329,400
Closed -$159K 162
2014
Q1
$105K Hold
329,400
﹤0.01% 171
2013
Q4
$112K Buy
+329,400
New +$398K ﹤0.01% 153

Other funds holding GCVRZ

Hudson Bay Capital Management's GCVRZ Position: Q1 2015 in Review

Hudson Bay Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2015, closing a stake of 329,400 shares — an estimated $260K sold.

Hudson Bay Capital Management first reported a position in GCVRZ in Q4 2013 and held it in 4 quarters. The position peaked at $260K in Q4 2014. 115 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2015.

  • Hudson Bay Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2015 after selling out during the quarter.
  • Hudson Bay Capital Management sold 329,400 Sanofi Contingent Value Rights shares in Q1 2015, an estimated $260K.
  • Hudson Bay Capital Management first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 4 quarters.
  • Hudson Bay Capital Management's Sanofi Contingent Value Rights position peaked at $260K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2015.

Based on Hudson Bay Capital Management's 13F filing for Q1 2015, filed 13 May 2015.